InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,260.22
(
0.27%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: binks post# 963

Tuesday, 07/20/2010 9:29:11 AM

Tuesday, July 20, 2010 9:29:11 AM

Post# of 80490
At this stage, missing or beating earnings will have no impact on Aiad's stock price. It's a non-event.

Upcoming catalysts that should impact pps include:

1) Ridaforolimus final analysis
2) Start of AP534 trial
3) AP534 partnership
4) New Rida trials (such as Rida/Dalo P2)
5) Current Rida P2 results (endometrial, prostate, nsclc)
6) Filing AP113 IND

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up